Course not currently available
Pharmaceutical Regulatory Affairs In: Russia, Belarus & Ukraine
Course
In Harrington Hall Hotel, London ()
Description
-
Type
Course
-
Duration
2 Days
This is a comprehensive seminar designed for all those needing to learn about recent and expected regulatory developments in the countries to be covered, to assist with future marketing authorisation applications and in-market regulatory compliance. Suitable for: Anyone in the pharma industry needing to learn about recent and expected regulatory changes in the countries covered.
Important information
Documents
- Pham Reg Aff in Russia_W
About this course
Scientists and Technical personnel: • Analytical R&D • Medical Directors • New Business Development • Pharmacists • Quality Compliance • Regulatory Affairs • Regulatory Authorities • Regulatory Compliance • Regulatory Registration
Reviews
Teachers and trainers (2)
Dr Natalia Nazarova
Head of Drug Regulatory, Safety and QA Department, Russia Roche Moscow
Natalia Morgunova
Regional Head of RA, QA Subdepartment , Novo Nordisk LLC, Moscow
Course programme
Course review:
The aim of this meeting is to provide an overview of recent regulatory developments in Pharmaceutical Regulatory Affairs in Russia, together with the markets of Belarus and Ukraine. The meeting will discuss the implications of the new Pharmaceutical Regulatory Law in Russia, that came into effect in September 2010.
An Essential Update on the New Russian Drug Legislation
- Understand the growing Markets of Russia, Belarus and Ukraine
- Gain Essential Information on the New Russian Drug Law
- Develop your Regulatory Strategy for Product Approval in these Countries.
- Discuss Requirements and Guidance for Drug Approval in Belarus & the Ukraine
- Gain Practical Advice from Industry Experts working in these Regions
Pharmaceutical Regulatory Affairs In: Russia, Belarus & Ukraine